跳至主要内容
临床试验/ACTRN12614000516684
ACTRN12614000516684终止未知

A randomised controlled trial to assess the impact of a technology mediated nurse-led intervention on management of chemotherapy side effects in haematological cancer patients.

Peter MacCallum Cancer Centre0 个研究点目标入组 222 人开始时间: 2014年5月15日最近更新:
适应症

试验速览

阶段
未知
状态
终止
发起方
入组人数
222

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Have a diagnosis of one of three haematological cancers (Hodgkin's lymphoma, Non-hodgkin's lymphoma or Chronic Lymphocytic Leukemia)
  • Be receiving four or more cycles of chemotherapy treatment Be over 18 years of age

排除标准

  • Having a key cognitive psychological disorder as assessed by the treatment team
  • Unable to speak/read/write English
  • Participating in a clinical drug trial

研究者

发起方
Peter MacCallum Cancer Centre

相似试验